Research library

A

grade

Orforglipron demonstrated non-inferiority to insulin glargine for cardiovascular safety in adults with type 2 diabetes, but gastrointestinal side effects were common.

HR 0.84; 95% CI 0.59-1.20; p<0.0001 for non-inferiority.

summary

A

grade

Relaxin may improve dyspnoea and reduce hospital stay in patients with acute heart failure, but further studies are needed to confirm these findings.

40% of patients in the relaxin 30 microg/kg group moderately or markedly improved dyspnoea at 6 h, 12 h, and 24 h vs 23% in the placebo group, p=0.044.

summary

A

grade

Serelaxin improved dyspnoea relief in patients with acute heart failure, but did not significantly affect readmission rates or cardiovascular death.

VAS AUC improvement of 448 mm × h, 95% CI 120-775; p=0·007 for serelaxin vs placebo.

summary

A

grade

Serelaxin did not show a significant benefit over placebo in reducing cardiovascular death or worsening heart failure in hospitalized patients with acute heart failure.

Hazard ratio for death from cardiovascular causes was 0.98; 95% CI, 0.83 to 1.15; P = 0.77.

summary

C

grade

Aging significantly alters the proteome of the retina and RPE/Cho in mice, which may have implications for understanding age-related macular degeneration.

Not reported in abstract.

summary

C

grade

GPX3 may enhance insulin receptor expression in adipose tissue, potentially influencing insulin sensitivity, but further research is needed to confirm these findings in humans.

Not reported in abstract.

summary

C

grade

Polystyrene microplastics can induce oxidative stress and alter gut microbiota in Mytilus edulis, highlighting potential ecological risks.

Superoxide dismutase (SOD) peaked at 87.3 U/mg on day 7.

summary

B

grade

The study found that young men had a significantly greater GH response to GHRH and GHRP-2 compared to older men, with abdominal fat negatively impacting GH release.

1.4-fold more GH release with l-arginine/GHRH in young than older men, P = 0.021.

summary

A

grade

This study found that gender and sex-steroid supplementation significantly affect growth hormone recovery from autoinhibition, with distinct effects based on the type of secretagogue used.

Nadir GH and peak GH during feedback were enhanced by GHRH or GHRP-2 (P < 0.001 for both).

summary

B

grade

Eliminating senescent pulmonary endothelial cells may worsen pulmonary hemodynamics, challenging the notion that senolytic therapies are universally beneficial.

Not reported in abstract.

summary

A

grade

Pemvidutide showed a significant improvement in MASH resolution at 24 weeks compared to placebo, but did not demonstrate significant fibrosis improvement.

MASH resolution without fibrosis worsening: 58% in 1.2 mg pemvidutide group, p<0.0001.

summary

D

grade

GLP-1 receptor agonists may offer new avenues for treating substance use disorders, but current trials are limited in scope and design.

Not reported in abstract.

summary

D

grade

Pemvidutide may significantly reduce liver fat and improve metabolic parameters in adults with MASH, but further long-term studies are needed to confirm these findings.

-52.90 MD liver fat content at 12 weeks, 95% CI -71.60 to -34.20, P < 0.00001

summary

D

grade

Dual and triple GLP-1-based polyagonists may improve liver health in patients with MASLD and MASH, but gastrointestinal side effects and the need for larger studies should be noted.

RR 3.32, 95% CI 2.28-4.84; I² = 20% for MASH resolution or histological improvement without worsening of fibrosis.

summary

B

grade

The study provides system-specific reference intervals for serum hCG in postmenopausal women, which may help reduce misclassification of hCG elevations.

97.5th percentile RIs were < 7.1, < 8.2, < 5.7, and < 5.9 IU/L for Systems A-D.

summary

B

grade

Low PAPP-A and PlGF levels, along with elevated AFP, may indicate a higher risk for pre-eclampsia in the first trimester, but further validation is necessary before clinical application.

AUC of 0.94 (95% CI 0.89–0.97) for the combination of AFP, PAPP-A, and PlGF.

summary

C

grade

Glutathione is necessary for maintaining proteostasis in hematopoietic stem cells but may not be crucial for preventing ferroptosis.

Not reported in abstract.

summary

C

grade

Dietary curcumin at 0.04% improved muscle quality and antioxidant status in green–Pacific abalone, but the implications for human consumption are not established.

0.04% curcumin increased muscle crude protein.

summary

B

grade

Efgartigimod may improve perioperative outcomes in gMG patients with thymoma, but further studies are needed to confirm these findings.

Not reported in abstract.

summary

B

grade

Efgartigimod may induce a partial response in refractory ITP, which can be enhanced by TPO-RAs, leading to sustained remission.

Not reported in abstract.

summary

D

grade

Panzyga treatment pathways were associated with lower total treatment costs and cost per responder compared to Vyvgart hytrulo at both 6 and 12 months.

$124,812 total treatment cost for Panzyga 1 g/kg at 6 months.

summary

B

grade

Diet-induced fasting ghrelin elevation may indicate recovery of insulin sensitivity and reduction in visceral fat, especially in men.

FGL increased by 10.5% in the green-MED group, P = 0.03 for green-MED vs HDG.

summary

B

grade

Glucocorticoids inhibit growth hormone release by enhancing beta-adrenergic responsiveness, with significant effects observed in a controlled study of normal volunteers.

GH peak: 10.7 +/- 3.9 vs. 20.3 +/- 5.5 micrograms/L; DEX vs. P study, respectively, P < 0.05.

summary

A

grade

CJC-1295 administration resulted in sustained increases in GH and IGF-I levels in healthy adults without serious adverse reactions.

Mean plasma GH concentrations increased by 2- to 10-fold for 6 d or more.

summary

B

grade

CJC-1295 significantly increases basal and mean GH levels and IGF-I production while preserving GH pulsatility, but the clinical implications of these changes remain unclear.

7.5-fold increase in basal GH levels, P < 0.0001.

summary